LL-37 (Cathelicidin) Dosage Guide
50/100 confidenceComplete guide to LL-37 (Cathelicidin) dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
500 mcg - 2 mg
Route
multiple
Frequency
2x daily
Detailed Dosage Information
Research protocols vary widely. Typical ranges: 50-200mcg administered subcutaneously 2-3 times weekly. Some protocols use higher doses for acute infections.
Administration Method
Subcutaneous injection. Can cause significant injection site reactions. Often used in conjunction with other immune-supporting protocols.
Research Backing
Wound-healing RCTs and antimicrobial studies; Phase I/II topical trials for venous ulcers and diabetic wounds.
Side Effects to Monitor
Injection site pain and reactions are common. May cause flu-like symptoms, temporary fatigue, or immune activation responses.
Safety Considerations & Risks
May overstimulate immune system in autoimmune conditions. Limited human research data. Quality and purity concerns with research products.